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Introduction
Primary microcephaly is a neurodevelopmental disorder char-
acterized by reduced brain size. The first causative gene identi-
fied encodes microcephalin (MCPH1), a protein implicated in 
DNA damage signaling via ataxia telangiectasia and Rad3 
related (ATR; Jackson et al., 2002; Alderton et al., 2006). Accord-
ingly,  the  clinical  features  of  MCPH1  syndrome  patients   
resemble those of Seckel syndrome, another microcephalic 
disorder that can be caused by mutations in ATR or defective 
ATR signaling (O’Driscoll et al., 2003; Alderton et al., 2004). 
Recently, it has been reported that mutations in pericentrin (PCNT), 
resulting in the loss of PCNT from the centrosome, also cause 
Seckel syndrome (Griffith et al., 2008). PCNT-Seckel cells, like 
ATR-Seckel cells, show defects in ATR-dependent G2/M check-
point control. This finding is further supported by the recent 
description of PCNT mutations in microcephalic osteodysplastic 
primordial dwarfism type II (MOPD II), a microcephalic dis-
order in which growth restriction is thought to be the consequence 
of mitotic failure (Rauch et al., 2008).
Mechanistically, it has been shown that MCPH1 prevents 
premature entry into mitosis and speculated that loss of PCNT 
might prevent centrosomal recruitment of the checkpoint kinase 
Chk1, an ATR target that controls initial activation of cyclin   
B–Cdk1 at the centrosome (Krämer et al., 2004; Alderton et al., 
2006; Löffler et al., 2006a; Griffith et al., 2008). Activation of 
cyclin B–Cdk1 is the key event required for the initiation of 
mitosis (Nurse, 1990). Cdk1 and cyclin B accumulate at the 
centrosome during interphase (Bailly et al., 1989, 1992), where 
initial activation of the cyclin B–Cdk1 complex occurs in late 
prophase (Jackman et al., 2003). The accumulation of active 
cyclin B–Cdk1 within the nucleus shortly thereafter irreversibly 
commits the cell to mitosis. Therefore, regulation of cyclin B–
Cdk1 activity at the centrosome is critical for controlling 
both cytoplasmic and nuclear mitotic events. During unper-
turbed cell cycles, activation of cyclin B–Cdk1 at the centro-
some is mediated by Cdc25B (De Souza et al., 2000; Krämer   
et al., 2004), which itself is positively regulated by phosphory-
lation at S353 by aurora A and inhibited by Chk1-mediated 
S230 phosphorylation at centrosomes (Dutertre et al., 2004; 
Löffler et al., 2006b; Schmitt et al., 2006).
To directly address whether loss of Chk1 from centrosomes 
constitutes a mechanism for premature entry into mitosis in micro-
cephaly syndromes, we examined both primary patient-derived 
  P
rimary microcephaly, Seckel syndrome, and micro-
cephalic osteodysplastic primordial dwarfism type II 
(MOPD II) are disorders exhibiting marked micro-
cephaly, with small brain sizes reflecting reduced neuron 
production during fetal life. Although primary microceph-
aly can be caused by mutations in microcephalin (MCPH1), 
cells from patients with Seckel syndrome and MOPD II 
harbor  mutations  in  ataxia  telangiectasia  and  Rad3   
related  (ATR)  or  pericentrin  (PCNT),  leading  to  dis-
turbed ATR signaling. In this study, we show that a lack of 
MCPH1 or PCNT results in a loss of Chk1 from centro-
somes with subsequently deregulated activation of cen-
trosomal cyclin B–Cdk1.
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To verify the interaction of MCPH1 with Chk1 in vivo, 
endogenous Chk1 was immunoprecipitated from U2OS cells 
transiently expressing MCPH1 fused to GFP (GFP-MCPH1), 
with GFP-MCPH1 being readily detectable in the immuno-
precipitates (Fig. 2 C). Similarly, immunoprecipitation of GFP-
MCPH1 using an anti-GFP antibody led to coimmunoprecipitation 
of endogenous Chk1. In contrast to the loss of centrosomal Chk1 
in MCPH1-deficient cells, the centrosomal levels of MCPH1 
remained virtually unchanged in U2OS cells transfected with 
Chk1 siRNA (Fig. 2 D), which is analogous to what has been 
reported for Chk1
/ DT40 cells (Jeffers et al., 2008). Thus, we 
conclude that MCPH1 and Chk1 interact with each other and 
that MCPH1 targets Chk1 to the centrosome.
MCPH1-dependent recruitment of Chk1 to 
centrosomes is mediated by PCNT
As PCNT has an established role in targeting regulatory proteins 
to the centrosome (Diviani et al., 2000; Chen et al., 2004), direct 
or indirect binding of Chk1 by PCNT might mediate the centro-
somal localization of Chk1 (Griffith et al., 2008). To determine 
whether the loss of Chk1 from centrosomes in MCPH1-deficient 
cells is a consequence of a shortage of centrosomal PCNT, con-
trol and MCPH1
427insA LBCs were immunostained for PCNT. 
In contrast to control LBCs, centrosomal PCNT signals were 
diminished in MCPH1
427insA cells (Fig. 3, A and B; and Fig. S2 A). 
Immunostaining of MCPH1 siRNA– and mock siRNA–treated 
U2OS cells with antibodies to PCNT led to similar results. Con-
sistently, centrosome preparations from MCPH1
427insA cells con-
tained less PCNT as compared with control LBCs (Fig. 2 B). 
Also,  GFP-MCPH1  coimmunoprecipitated  with  endogenous 
PCNT when transiently expressed in U2OS cells (Fig. S2 B). 
Similarly, immunoprecipitation of GFP-MCPH1 led to coimmuno-
precipitation of endogenous PCNT. Thus, MCPH1 and PCNT 
interact with each other, and in addition to a loss of centrosomal 
Chk1, PCNT is depleted from centrosomes in MCPH1-deficient 
cells. To the contrary, PCNT deficiency did not impact on the 
abundance of MCPH1 at centrosomes in PCNT
3109G>T or PCNT 
siRNA–treated U2OS cells (Fig. 2 A). Also, the centrosomal lev-
els of PCNT remained unchanged in both U2OS cells transfected 
with Chk1 siRNA and Chk1
/ DT40 cells (Fig. 3 C; Zachos   
et al., 2003).
To examine the relationship between PCNT and Chk1 in 
more detail, endogenous PCNT was immunoprecipitated from 
control and MCPH1
427insA LBCs, respectively. Endogenous 
Chk1  was  detectable  in  immunoprecipitates  from  both  cell 
types (Fig. 3 D). Similarly, immunoprecipitation of endogenous 
Chk1  led  to  coimmunoprecipitation  of  endogenous  PCNT. 
Thus, PCNT and Chk1 interact with each other independent 
from the presence of MCPH1. Collectively, we conclude that 
MCPH1 contributes to the centrosomal localization of PCNT 
and that both MCPH1 and PCNT are required to recruit Chk1 to 
the centrosome.
To further confirm an interaction between Chk1, MCPH1, 
and PCNT, we size fractionated whole cell lysates from U2OS 
cells transiently transfected with GFP-MCPH1 by Superose 6 
gel filtration chromatography (Fig. 3 E). As additional evi-
dence for complex formation, all three proteins comigrated   
cells from individuals with MCPH1
427insA (MCPH1 syndrome) 
and PCNT
3109G>T (MOPD II) mutations as well as cells treated 
with MCPH1- and PCNT-specific siRNAs, respectively.
Results and discussion
Chk1 is lost from centrosomes in both 
MCPH1- and PCNT-deficient cells
First, we analyzed whether deficiency of either MCPH1 or PCNT 
impacts on the abundance of Chk1 at centrosomes in human 
cells. Although immunofluorescence microscopy analysis with a 
monoclonal antibody against Chk1 revealed a pronounced cen-
trosomal staining in both U2OS and control lymphoblastoid 
cells (LBCs), Chk1 levels were reduced at centrosomes in 
MCPH1 and PCNT siRNA–treated U2OS cells as well as in pri-
mary MCPH1
427insA and PCNT
3109G>T cells from patients with 
primary microcephaly or MOPD II, respectively (Fig. 1, A–C; 
and Fig. S1, A–C). This effect was independent from the cell 
cycle stage, as Chk1 levels were reduced to a similar extent in both 
cells containing a single centrosome, reflecting G0/G1 phase, and 
two centrosomes, reflecting S/G2 phase, respectively (Fig. S1 C). 
Virtually identical results were obtained when a rabbit poly-
clonal antibody against Chk1 was used (unpublished data).
Next, we examined the association of Chk1 with centro-
somes using centrosome preparations from MCPH1
427insA as 
well as PCNT
3109G>T cells and normal LBCs. Although compa-
rable protein amounts were loaded, the centrosome preparations 
from MCPH1
427insA and PCNT
3109G>T cells contained reduced 
levels of Chk1 as compared with centrosomes from control 
LBCs (Fig. 1 D). The loss of Chk1 from centrosomes in MCPH1- 
and PCNT-deficient cells was not attributable to a general short-
age of cellular Chk1 in these cells, as whole cell lysates from 
control and MCPH1
427insA or PCNT
3109G>T LBCs contained 
almost identical Chk1 levels (Fig. 1 E). Likewise, we have 
described previously that Chk1 is lost from centrosomes during 
mitosis, although total cellular Chk1 levels are not reduced dur-
ing this phase of the cell cycle (Krämer et al., 2004). On the 
basis of these combined in situ and biochemical analyses, we 
conclude that in MCPH1- and PCNT-deficient cells, Chk1 is 
lost from centrosomes.
MCPH1 targets Chk1 to the centrosome
How Chk1 is recruited to interphase centrosomes during unper-
turbed cell cycles remains unknown. MCPH1 has been reported 
to localize to centrosomes in chicken DT40 cells and to directly 
interact with Chk1 in vitro (Alderton et al., 2006; Jeffers et al., 
2008), thereby possibly contributing to the localization of Chk1 
to centrosomes. To test for this possibility, we first confirmed 
that endogenous human MCPH1 localizes to interphase cen-
trosomes in control but not MCPH1
427insA LBCs or MCPH1 
siRNA–treated U2OS cells by immunofluorescence microscopy 
using an antibody raised against an N-terminal fragment (1–267 aa) 
of MCPH1 (CCU.M1; see Materials and methods; Fig. 2 A and 
Fig. S1 D). Also, in contrast to MCPH1
427insA LBCs, MCPH1 
was detectable in centrosome preparations from control LBCs 
(Fig. 2 B). Therefore, we conclude that MCPH1 indeed local-
izes to centrosomes.1151 LOSS OF CENTROSOMAL CHK1 IN MICROCEPHALY SYNDROMES • Tibelius et al.
MCPH1 or PCNT depletion–induced loss 
of Chk1 from centrosomes leads to 
premature activation of cyclin B–Cdk1
Centrosome-associated Chk1 prevents premature activation of 
cyclin B–Cdk1 and thereby mitotic entry by inhibitory phosphory-
lation of centrosomal Cdc25B at S230 with consecutive inhibi-
tion of P-Y15-Cdk1 dephosphorylation (Krämer et al., 2004; 
Schmitt et al., 2006). To determine whether down-regulation of 
MCPH1 or PCNT has an impact on the phosphorylation status   
of the centrosomal fractions of Cdc25B and Cdk1, primary 
together in two fractions, which correspond to a molecular 
mass of >2 MD.
We next examined other components of the centrosome to 
establish whether they were affected by the absence of MCPH1 
or PCNT (Fig. S2, C and D). Centrin, Nek2, and Cep170 were 
all  localized  normally.  However,  -tubulin  was  significantly   
reduced  at  interphase  centrosomes  in  MCPH1
427insA  and 
PCNT
3109G>T LBCs as compared with control LBCs, which is 
consistent  with  what  has  been  described  for  mitotic  PCNT-
Seckel cells (Griffith et al., 2008).
Figure 1.  Chk1 levels are reduced at centrosomes in both MCPH1- and PCNT-deficient cells. (A) Normal, MCPH1
427insA, and PCNT
3109G>T LBCs as well 
as U2OS cells transfected with luciferase- (as control [siLUC]), MCPH1-, or PCNT-specific siRNA were costained with mouse anti-Chk1 (red) and rabbit   
anti–-tubulin (green) antibodies and analyzed by confocal microscopy. Bar, 10 µm. (B) The mean percentages of cells with centrosomal colocalization 
of -tubulin and Chk1 are indicated. Error bars represent the standard deviation after combining the results of three different experiments. Statistical significance 
versus control (LBC) by two-tailed Student’s t test is as follows: ***, P = 9 × 10
6 (MCPH1
427insA); P = 0.00003 (PCNT
3109G>T). (C) Quantification of pixel 
intensity profiles constructed from optically sectioned (z axis) fluorescence images of control, MCPH1
427insA, and PCNT
3109G>T LBCs. Error bars represent 
standard deviations from the analysis of 100 cells. Statistical significance versus control (LBC) by two-tailed Student’s t test is as follows: ***, P = 1.4 × 10
7 
(MCPH1
427insA); P = 9.8 × 10
12 (PCNT
3109G>T). (D) Loss of Chk1 protein in isolated centrosome preparations. Immunoblots were performed on three sucrose 
gradient fractions of centrosome preparations (left) and whole cell lysates (right) as an input control from normal, MCPH1
427insA, and PCNT
3109G>T LBCs 
using antibodies against Chk1 and, for comparison, Nek2 (a centrosomal protein) and Mcm7 (a nuclear protein). For whole cell lysates, actin was included 
as a loading control. (E) Western blot analysis of PCNT, MCPH1, and Chk1 in whole cell lysates from control, MCPH1
427insA, and PCNT
3109G>T LBCs. Actin 
was included as a loading control. Arrowheads point to centrosomes, which are shown enlarged in insets.JCB • VOLUME 185 • NUMBER 7 • 2009   1152
well as PCNT
3109G>T cells and normal LBCs. Although compa-
rable protein amounts were loaded, the centrosome preparations 
from MCPH1
427insA and PCNT
3109G>T cells contained reduced 
levels of P-S230-Cdc25B or P-Y15-Cdk1 as compared with 
control LBCs (Fig. 4 F). Similar to immunofluorescence stain-
ings, reduced levels of P-Y15-Cdk1 at centrosomes in MCPH1- 
and PCNT-deficient cells were not attributable to a general 
shortage of centrosomal Cdk1 in these cells, as centrosome 
preparations from control and MCPH1
427insA or PCNT
3109G>T 
LBCs contained almost identical Cdk1 levels (Fig. 4 F).
These findings suggest that MCPH1 or PCNT depletion–
induced loss of Chk1 from centrosomes leads to reduced inhibi-
tory phosphorylation of both centrosomal Cdc25B at S230 and 
Cdk1 at Y15 and therefore to premature entry into mitosis. In 
agreement with these findings, it has been reported recently that 
MCPH1
427insA and PCNT
3109G>T LBCs as well as control LBCs 
were synchronized in G1/early S phase by a mimosine block and 
released for 8 h to reach G2 phase. Subsequently, cells were co-
immunostained with antibodies to P-S230-Cdc25B or P-Y15-Cdk1 
and -tubulin. Although centrosomes were decorated with anti–
P-S230-Cdc25B in 65.7 ± 5.1% in control LBCs, only 14.0 ± 
2.6% and 36.7 ± 1.5% of MCPH1
427insA and PCNT
3109G>T LBCs 
harbored centrosomes that stained positive for P-S230-Cdc25B 
(Fig. 4, A and B). Similarly, in contrast to control LBCs (27.3 ± 
5.1%), only 5.7 ± 1.5% and 10.0 ± 1.7% of MCPH1
427insA and 
PCNT
3109G>T LBCs, respectively, harbored centrosomes with dis-
cernible P-Y15-Cdk1 decoration, despite almost all centrosomes 
stained positive for total Cdk1 (Fig. 4, C–E).
Next, we examined the phosphorylation status of Cdc25B 
and Cdk1 using centrosome preparations from MCPH1
427insA as 
Figure 2.  MCPH1 interacts with and targets Chk1 to the centrosome. (A) Control, MCPH1
427insA, and PCNT
3109G>T LBCs as well as U2OS cells transfected 
with luciferase- (as control [siLUC]), MCPH1-, or PCNT-specific siRNA were costained with mouse anti-MCPH1 (red) and rabbit anti–-tubulin (green) anti-
bodies and analyzed by confocal microscopy. (B) Reduced levels of PCNT in isolated centrosome preparations from MCPH1
427insA LBCs. Immunoblots were 
performed on three sucrose gradient fractions of centrosome preparations (left) and whole cell lysates (right) as an input control from normal, MCPH1
427insA, 
and PCNT
3109G>T LBCs using antibodies against PCNT, MCPH1, and, for comparison, Nek2 as a loading control and Mcm7 to exclude nuclear contami-
nation. For whole cell lysates, actin was included as a loading control. (C) Transiently expressed GFP-MCPH1 and Chk1 interact with each other in vivo. 
Chk1 was immunoprecipitated from U2OS cells 24 h after transient transfection with GFP-MCPH1. Reciprocally, GFP-MCPH1 was immunoprecipitated 
using an anti-GFP antibody. Immunoprecipitation with an anti-HA antibody served as a negative control. Input represents 10% of the amount used for 
immunoprecipitation. White lines indicate that intervening lanes have been spliced out. (D) Depletion of Chk1 does not impact on centrosomal MCPH1 
levels. U2OS cells transfected with either luciferase- or Chk1-specific siRNA were costained with mouse anti-MCPH1 (red) and rabbit anti–-tubulin (green) 
antibodies (top) or mouse anti-Chk1 (red) and rabbit anti–-tubulin (green) antibodies (bottom) and analyzed by confocal microscopy. Arrowheads point 
to centrosomes, which are shown enlarged in insets. Bars, 10 µm.1153 LOSS OF CENTROSOMAL CHK1 IN MICROCEPHALY SYNDROMES • Tibelius et al.
flow cytometry measurement using P-S10–histone H3 as a 
mitotic marker. 72 h after MCPH1 or PCNT siRNA transfection, 
significantly more cells were in late G2 or mitosis (Fig. 5 A). 
Similar results were obtained when the cell cycle distribution of 
exponentially growing control, MCPH1
427insA, and PCNT
3109G>T 
LBCs was examined (Fig. 5 B and Fig. S3 A). In addition, transient 
transfection of MCPH1
427insA LBCs with wild-type MCPH1-Flag 
human and Drosophila melanogaster MCPH1-deficient cells 
have low levels of total P-Y15-Cdk1 in S and G2 phases, result-
ing in accelerated mitotic entry in MCPH1
427insA LBCs and pre-
mature centrosome separation in MCPH1 mutant Drosophila 
embryos (Alderton et al., 2006; Brunk et al., 2007). To assay for 
the rates of cells in late G2 or mitosis, U2OS cells treated with 
mock-, MCPH1-, or PCNT-specific siRNAs were examined by 
Figure 3.  MCPH1 recruits Chk1 to the centrosome via PCNT. (A) Centrosomal PCNT levels are reduced in MCPH1
427insA and PCNT
3109G>T LBCs relative 
to control lymphoblasts. Normal, MCPH1
427insA, and PCNT
3109G>T LBCs as well as U2OS cells transfected with luciferase- (as control [siLUC]), MCPH1-, or 
PCNT-specific siRNA were costained with rabbit anti-PCNT (green) and mouse anti–-tubulin (red) antibodies and analyzed by confocal microscopy. 
(B) Quantification of pixel intensity profiles constructed from optically sectioned (z axis) fluorescence images of normal cells. Error bars represent standard 
deviations from the analysis of 100 cells. Statistical significance versus control (LBC) by two-tailed Student’s t test is as follows: ***, P = 7.2 × 10
6 
(MCPH1
427insA). (C) Control and Chk1
/ chicken DT40 cells as well as U2OS cells transfected with luciferase- or Chk1-specific siRNA were costained 
with rabbit anti-PCNT (green) and mouse anti–-tubulin (red) and analyzed by confocal microscopy. (D) Endogenous PCNT and Chk1 interact with each 
other in vivo. Endogenous Chk1 was detected in immunoprecipitates using an anti-PCNT antibody in both control and MCPH1
427insA LBCs. Reciprocally, 
endogenous PCNT was detectable after immunoprecipitation of Chk1 in both cell lines as well. Immunoprecipitation with an anti-HA antibody served as 
a negative control. Input represents 10% of the amount used for immunoprecipitation. White lines indicate that intervening lanes have been spliced out.   
(E) Cofractionation of PCNT, MCPH1, and Chk1 in U2OS whole cell lysates. Lysates were prepared from U2OS cells transiently transfected with GFP-MCPH1 
24 h before lysis and size fractionated by fast protein liquid chromatography using a Superose 6 column. Proteins from consecutive fractions were analyzed 
by Western blotting using antibodies to PCNT, GFP, and Chk1. The size of marker proteins is shown on top. Numbers in red indicate the fractions that 
contain all three proteins (GFP-MCPH1, PCNT, and Chk1). Arrowheads point to centrosomes, which are shown enlarged in insets. Bars, 10 µm.JCB • VOLUME 185 • NUMBER 7 • 2009   1154
Figure 4.  Loss of Chk1 from centrosomes induces activation of centrosome-associated Cdc25B and Cdk1. (A, C, and D) Normal, MCPH1
427insA, and 
PCNT
3109G>T LBCs were synchronized in G1/early S phase by a mimosine block, released for 8 h to reach G2 phase, and subsequently costained with rabbit 
anti–P-S230-Cdc25B (green) and mouse anti–-tubulin (red) antibodies (A), rabbit anti–P-Y15-Cdk1 (green) and mouse anti–-tubulin (red) antibodies (C), 
or mouse anti-Cdk1 (red) and rabbit anti–-tubulin (green) antibodies (D) and analyzed by confocal microscopy. (B) Loss of Chk1 from centrosomes induces 
activation of centrosome-associated Cdc25B. The mean percentages of cells with centrosomal colocalization of -tubulin and P-S230-Cdc25B are indi-
cated. Statistical significance versus control (LBC) by two-tailed Student’s t test is as follows: ***, P = 0.0006 (MCPH1
427insA); **, P = 0.006 (PCNT
3109G>T). 
(E) Loss of Chk1 from centrosomes induces activation of centrosome-associated Cdk1. The mean percentages of cells with centrosomal colocalization of 
-tubulin and total Cdk1 (light gray bars) or P-Y15-Cdk1 (dark gray bars) are indicated. Statistical significance versus control (LBC) by two-tailed Student’s 
t test is as follows: *, P = 0.013 (MCPH1
427insA); P = 0.019 (PCNT
3109G>T). (F) Reduced levels of P-S230-Cdc25B and P-Y15-Cdk1 in isolated centrosome 
preparations from MCPH1
427insA and PCNT
3109G>T LBCs. Immunoblots were performed on three sucrose centrifugation fractions of centrosome preparations 
(left) and whole cell lysates (right) as an input control from control (LBC), MCPH1
427insA, and PCNT
3109G>T LBCs using antibodies against P-S230-Cdc25B, 
P-Y15-Cdk1, Cdk1, and, for comparison, Nek2 as a loading control and Mcm7 to exclude nuclear contamination. For whole cell lysates, antibodies to 
Cdc25B, Cdk1, and actin were included. Arrowheads point to centrosomes, which are shown enlarged in insets. Error bars represent the standard devia-
tion after combining the results of three different experiments. Bars, 10 µm.1155 LOSS OF CENTROSOMAL CHK1 IN MICROCEPHALY SYNDROMES • Tibelius et al.
led to a significant reduction of G2/mitotic cells from 1.28 ± 0.2% 
after mock transfection to 0.75 ± 0.1% 12 h after transfection 
with MCPH1-Flag (Fig. S3 B).
Time-lapse  video  microscopy  of  MCPH1  and  PCNT 
siRNA–treated U2OS cells revealed that mitosis in these cells 
was prolonged as compared with U2OS cells treated with lucif-
erase siRNA (Fig. S3, C–E). After PCNT siRNA treatment, the 
frequency of cells dying out of mitosis was increased as well.
Forced immobilization of Chk1 at 
centrosomes leads to accumulation of 
MCPH1-deficient cells with premature 
chromosome condensation (PCC) in  
G2 phase
MCPH1 deficiency leads to a striking elevation in G2 phase–
like cells with PCC mediated by deregulated activity of nu-
clear condensin II (Trimborn et al., 2004, 2006; Alderton   
et al., 2006). If MCPH1 indeed functions to locally regulate 
activation of Cdk1 via centrosomal targeting of Chk1, then 
specific interference with centrosome-associated Chk1 should 
alter the impact of MCPH1 depletion on the G2/M transition. 
To address this issue, we took advantage of a U2OS clone con-
ditionally expressing GFP-Chk1 fused to the PCNT-AKAP450 
centrosomal-targeting (PACT) domain of AKAP450, an im-
mobile protein of the pericentriolar matrix (Gillingham and 
Munro, 2000; Krämer et al., 2004). In these cells, forced im-
mobilization of wild-type Chk1 to centrosomes impairs acti-
vation of centrosome-associated Cdk1 and thereby entry into 
mitosis (Krämer et al., 2004). When parental U2OS cells as 
well  as  wild-type  and  kinase-dead  versions  of  GFP-Chk1-
PACT–expressing cells were treated with an MCPH1-specific 
siRNA, 34.0 ± 5.5% of wild-type but only 14.2 ± 3.9% of 
kinase-dead GFP-Chk1-PACT–expressing cells and 16.2 ± 2.3% 
of parental U2OS cells showed a PCC phenotype 72 h after 
transfection (Fig. 5, C and D). These findings suggest that 
down-regulation  of  MCPH1  induces  premature  entry  into 
mitosis via depletion of the centrosomal pool of Chk1. Forced 
immobilization of Chk1 at the centrosome prevents cell cycle 
progression into mitosis, leading to accumulation of cells with 
PCC in G2 phase.
Figure  5.  Down-regulation  of  MCPH1  in-
duces premature entry into mitosis via deple-
tion of centrosomal Chk1. (A and B) U2OS 
cells  transfected  with  luciferase-  (as  control 
[siLUC]),  MCPH1-,  or  PCNT-specific  siRNA 
(A)  as  well  as  normal,  MCPH1
427insA,  and 
PCNT
3109G>T  LBCs  (B)  were  costained  with 
propidium  iodide  and  anti–P-S10–histone 
H3 and analyzed by fluorescence-activated 
cell sorting to quantify cells in mitosis. Statisti-
cal significance versus control by two-tailed 
Student’s t test is as follows: (A) *, P = 0.02 
(U2OS-siMCPH1);  **,  P  =  0.001  (U2OS-
siPCNT); (B) **, P = 0.009 (MCPH1
427insA); 
P = 0.09 (PCNT
3109G>T). (C) Parental U2OS 
cells  or  U2OS  cells  conditionally  express-
ing  wild-type  (Chk1[WT])  or  kinase-dead 
(Chk1[KD]) GFP-Chk1-PACT were transfected 
with  MCPH1-specific  siRNA  and  analyzed 
by fluorescence microscopy. The mean per-
centages  of  cells  with  PCC  are  indicated. 
Statistical  significance  versus  Chk1(WT)  by 
two-tailed Student’s t test is as follows: ***,   
P = 0.0008 (U2OS); P = 0.0002 (Chk1[KD]). 
(D) Characterization of the PCC phenotype.   
U2OS cells were transfected with luciferase- or   
MCPH1-specific siRNA and immunostained   
with antibodies to cyclin B1 (top), lamin A   
(middle),  and  P-S10–histone  H3  (pH3; 
bottom).  DNA  was  counterstained  with   
To-Pro 3. After transfection with MCPH1-specific 
siRNA, PCC cells have an intact nuclear 
membrane as judged by lamin A staining, 
are P-S10–histone H3 negative, and show no   
nuclear cyclin B1 accumulation, thereby dem-
onstrating  that  they  exhibit  G2  rather  than   
mitotic characteristics. Error bars represent the 
standard deviation after combining the results 
of three different experiments. Bars, 10 µm.JCB • VOLUME 185 • NUMBER 7 • 2009   1156
Antibodies
A phospho-specific rabbit antiserum to S230-Cdc25B (SE4394) was raised 
and characterized as described previously (Schmitt et al., 2006). Mouse 
monoclonal antibodies to Cdk1 and GFP (B-2), rabbit antiserum to actin   
(I-19), Chk1 (FL-476), and HA (Y11) as well as goat and donkey antisera 
to HRP were obtained from Santa Cruz Biotechnology, Inc.; a mouse mono-
clonal antibody to Chk1 (DCS-310) and a rabbit antiserum to -tubulin 
were obtained from Sigma-Aldrich; a mouse monoclonal antibody to   
-tubulin (TU-30) was obtained from Exbio; a mouse monoclonal antibody 
to Nek2 was obtained from BD; a goat antiserum to MCPH1 was obtained 
from R&D Systems; rabbit antiserum to PCNT, P-Y15-Cdk1, and P-S10– 
histone H3 were obtained from Abcam, EMD, and Millipore, respectively. 
Mouse monoclonal antibodies to centrin, Cep170, and lamin A were pro-
vided by J.L. Salisbury (Mayo Clinic, Rochester, MN), E.A. Nigg (Univer-
sity of Basel, Basel, Switzerland), and H. Herrmann-Lerdon (German 
Cancer Research Center, Heidelberg, Germany), respectively. Highly 
cross-absorbed secondary reagents Alexa Fluor 488 and 568 were ob-
tained from Invitrogen.
RNA interference
For siRNA-mediated ablation of Chk1, MCPH1, and PCNT, U2OS cells 
were transfected twice (at 0 and 24 h) with the following oligonucleotide 
sequences: Chk1 siRNA, 5-GGACUUCUCUCCAGUAAACdTdT-3; MCPH1 
siRNA, 5-AGGAAGUUGGAAGGAUCCAdTdT-3; PCNT siRNA, 5-GCA-
GCUGAGCUGAAGGAGAdTdT-3; and luciferase siRNA, 5-UAAGGCU-
AUGAAGAGAUACdTdT-3 by Oligofectamine reagent (Invitrogen). Cells 
were harvested 72 h after the first transfection.
Isolation and analysis of human centrosomes
Centrosomes were isolated from control, MCPH1
427insA, and PCNT
3109G>T 
LBCs as described previously (Moudjou and Bornens, 1994).
Gel filtration
Whole cell lysates were cleared by centrifugation and passaged through 
a 0.2-µm filter. 200 µl cleared lysate was applied to a Superose 6 gel fil-
tration column (HR 10/30; GE Healthcare) and resolved on a fast protein 
liquid chromatography system (GE Healthcare) according to the manufac-
turer’s instructions.
Immunoprecipitation
For immunoprecipitation, cells were lysed with RIPA buffer (50 mM Tris, pH 
8.0, 150 mM NaCl, 1% NP-40, 1 mM EDTA, 0.2 mM PMSF, 5 mM NaF, 
and 1 mM Na3VO4) containing a protease inhibitor cocktail (Roche). Sub-
sequently, the cell lysates were centrifuged at 14,000 g for 20 min. Precipi-
tating  antibodies  were  preincubated  with  protein  G/A  agarose  beads 
(50% slurry; Roche) for 1 h at room temperature followed by three washes 
for 5 min each in RIPA buffer and overnight incubation at 4°C after adding 
aliquots of the cell lysate supernatant. Negative controls were generated 
by immunoprecipitation with an antibody to HA (Clontech Laboratories, 
Inc.). After three washes for 5 min each in RIPA buffer, the proteins were 
analyzed by immunoblotting.
Transfection
U2OS cells were transiently transfected with 2 µg pEGFP-C1-MCPH1 using 
Fugene 6 (Roche) and MCPH1
427insA LBCs with 1.5 µg pCMV-Tag4A-
MCPH1 by electroporation using a MicroPorator (MP-100; Peqlab) ac-
cording to the manufacturer’s instructions.
Generation of an MCPH1-specific monoclonal antibody
A bacterially expressed and affinity-purified His-tagged MCPH1 fragment 
(MCPH1-1_267aa.HIS) was used to immunize mice following a modified 
standard immunization protocol (Köhler and Milstein, 1975). Fusions re-
sulted in the generation of six specific monoclonal antibodies that were 
subsequently subcloned. Specificity of the antibody that was eventually 
used for further experiments (CCU.M1), which was typed as mouse IgM, 
was verified by using bacterially expressed recombinant proteins as well 
as control and MCPH1
427insA LBCs for Western blotting and U2OS cells for 
immunofluorescence staining.
Live cell imaging
Live cell imaging of cells growing in CO2-independent Leibovitz medium 
(Invitrogen) on microdishes (Ibidi) was performed at 37°C in a humidified 
atmosphere containing 5% CO2 using the BioStation IM system (Nikon) 
equipped with a 63× 0.8 NA Plan Fluor objective (Nikon).
In addition to MCPH1, three other primary microcephaly 
genes have been identified, ASPM, CENPJ, and CDK5RAP2 
(Bond et al., 2002, 2005; Bond and Woods, 2006). Their pro-
tein products have a centrosomal localization in common and 
are required for centrosomal function. Therefore, a unifying 
theme for primary microcephaly of genes functioning in the 
process of cell division has been proposed. However, in con-
trast to mutations in ATR, MCPH1, and PCNT, which can re-
duce both body and brain size, effects of ASPM, CENPJ, and 
CDK5RAP2 mutations are restricted to the brain, presumably 
by  acting  specifically  on  neurogenic  mitosis  (Bond  et  al., 
2005). Our data provide evidence that the recruitment of Chk1 
to centrosomes depends on both MCPH1 and PCNT during un-
perturbed  cell  cycle  progression.  In  MCPH1  syndrome  and 
MOPD II, which result from mutations in MCPH1 and PCNT, 
respectively, loss of Chk1 from centrosomes leads to unsched-
uled entry into mitosis. Consequently, loss of regulatory re-
straints  on  the  initial  activation  of  cyclin  B–Cdk1  at  the 
centrosome might be a common final path in microcephalic 
disorders with reduced body size, thereby explaining for the 
first time why seemingly unrelated genetic defects result in a 
common human disease phenotype.
Materials and methods
Cell culture
U2OS were maintained in DME with 10% FCS. Control, MCPH1
427insA, 
and PCNT
3109G>T LBCs (Alderton et al., 2006; Rauch et al., 2008) were 
cultured in RPMI 1640 supplemented with 15% FCS. Derivatives of U2OS 
cells conditionally expressing wild-type or kinase-dead alleles of GFP-
Chk1-PACT were generated as reported previously (Krämer et al., 2004). 
DT40 cells were maintained in RPMI 1640 with 10% chicken serum 
(Sigma-Aldrich).
Mimosine release
Cells were incubated overnight in 0.2 mM mimosine for synchronization at 
G1/early S phase. For release, cells were washed and seeded into com-
plete medium for up to 12 h before further processing.
Microscopy
U2OS  cells  grown  on  glass  coverslips  or  control,  MCPH1
427insA,  and 
PCNT
3109G>T LBCs cytocentrifuged on glass slides at 800 rpm for 4 min using 
a cytocentrifuge (Cytospin 3; Shandon) were fixed in 20°C methanol/
acetone (1:1) for 7 min. After fixation, the cells were permeabilized in 1% 
Triton X-100 and 0.5% NP-40 for 10 min. Immunofluorescence microscopy 
was performed with the combinations of antibodies specified in Figs. 1–5, 
S1, and S2. Fluorescence images were captured and processed using a true 
confocal scanner laser-scanning microscope (SP2; Leica) equipped with con-
focal software (2.61; Leica) and a Plan Apo 63× 1.32 NA oil immersion 
objective (Leica). Images were cropped and processed using Photoshop 
(CS3; Adobe). Matching confocal planes were analyzed in all colocaliza-
tion experiments. For the quantification of centrosomal Chk1, PCNT, and   
-tubulin signals, 3D datasets were collected using a confocal laser-scanning 
microscope (LSM 710; Carl Zeiss, Inc.) equipped with Axiovision software 
(4.7.2; Carl Zeiss, Inc.) and a Plan Apo 63× 1.4 NA oil immersion objec-
tive (Carl Zeiss, Inc.). A defined volume containing the centrosome was used 
to measure the total intensity of the signal. Signal intensities of centrosomes 
from 100 interphase cells per cell line were averaged, and relative intensi-
ties in comparison with control LBCs were calculated. 3D picture reconstruc-
tion was performed using ImageJ software (1.40g; provided by W. Rasband, 
National Institutes of Health, Bethesda, MD).
Plasmids
MCPH1 cDNA (GenBank/EMBL/DDBJ accession no. NM_024596) was 
cloned into pEGFP-C1 (Clontech Laboratories, Inc.) containing an N-terminal 
GFP tag as well as into pCMV-Tag4A (Agilent Technologies) containing a 
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Flow cytometry
Cell cycle analysis by flow cytometry including the quantification of cells in 
mitosis by P-S10–histone H3 staining was performed as previously de-
scribed (Rebacz et al., 2007).
Online supplemental material
Fig. S1 presents a time course of siRNA-mediated depletion of PCNT and 
MCPH1 as well as a characterization of a novel anti-MCPH1 antibody and 
illustrates that Chk1 levels are reduced at centrosomes in both MCPH1- 
and PCNT-deficient cells. Fig. S2 illustrates that centrosomal PCNT levels 
are reduced in MCPH1
427insA and PCNT
3109G>T LBCs irrespective of their 
cell cycle status, that transiently expressed GFP-MCPH1 and endogenous 
PCNT interact with each other in vivo, and that centrosomal levels of   
centrin, Nek2, and Cep170, but not -tubulin, are unchanged in MCPH1- 
and PCNT-deficient cells. Fig. S3 depicts the cell cycle distribution of 
MCPH1
427insA  and  PCNT
3109G>T  LBCs,  demonstrates  that  rescue  of 
MCPH1
427insA LBCs via transfection with wild-type MCPH1-Flag leads to a 
restored mitotic index, and outlines the mitotic fate of MCPH1- and PCNT-
depleted U2OS cells. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200810159/DC1.
We thank D.A. Gillespie for providing Chk1
/ DT40 cells, J.L. Salisbury, 
E.A.  Nigg,  and  H.  Herrmann-Lerdon  for  providing  antibodies  to  centrin, 
Cep170, and lamin A, respectively, S. Poppelreuther (Carl Zeiss, Inc., Heidel-
berg, Germany) for technical support, and B. Schreiter and S. Franz for excel-
lent technical assistance.
We are grateful to the Deutsche Forschungsgemeinschaft and the Euro-
pean Commission (project Genome Instability in Cancer and Precancer) for   
financial support.
Submitted: 24 October 2008
Accepted: 29 May 2009
References
Alderton, G.K., H. Joenje, R. Varon, A.D. Borglum, P.A. Jeggo, and M. O’Driscoll. 
2004. Seckel syndrome exhibits cellular features demonstrating defects in 
the ATR-signalling pathway. Hum. Mol. Genet. 13:3127–3138. 
Alderton, G.K., L. Galbiati, E. Griffith, K.H. Surinya, H. Neitzel, A.P. Jackson, 
P.A. Jeggo, and M. O’Driscoll. 2006. Regulation of mitotic entry by micro-
cephalin and its overlap with ATR signalling. Nat. Cell Biol. 8:725–733. 
Bailly, E., M. Doree, P. Nurse, and M. Bornens. 1989. P34
cdc2 is located in both 
the nucleus and cytoplasm; part is centrosomally associated at G2/M and 
enters vesicles at anaphase. EMBO J. 8:3985–3995.
Bailly, E., J. Pines, T. Hunter, and M. Bornens. 1992. Cytoplasmic accumulation 
of cyclin B1 in human cells: association with a detergent-resistant com-
partment within the centrosome. J. Cell Sci. 101:529–545.
Bond, J., and C.G. Woods. 2006. Cytoskeletal genes regulating brain size. Curr. 
Opin. Cell Biol. 18:95–101. 
Bond, J., E. Roberts, G.H. Mochida, D.J. Hampshire, S. Scott, J.M. Askham, K. 
Springell, M. Mahadevan, Y.J. Crow, A.F. Markham, et al. 2002. ASPM is 
a major determinant of cerebral cortical size. Nat. Genet. 32:316–320. 
Bond,  J.,  E.  Roberts,  K.  Springell,  S.  Lizarraga,  S.  Scott,  J.  Higgins,  D.J. 
Hampshire, E.E. Morrison, G.F. Leal, E.O. Silva, et al. 2005. A centro-
somal mechanism involving CDK5RAP2 and CENPJ controls brain size. 
Nat. Genet. 37:353–355. 
Brunk, K., B. Vernay, E. Griffith, N.L. Reynolds, D. Strutt, P.W. Ingham, and 
A.P. Jackson. 2007. Microcephalin coordinates mitosis in the syncytial 
Drosophila embryo. J. Cell Sci. 120:3578–3588. 
Chen,  D.,  A.  Purohit,  E.  Halilovic,  S.J.  Doxsey,  and  A.C.  Newton.  2004. 
Centrosomal anchoring of protein kinase C betaII by pericentrin controls 
microtubule organization, spindle function, and cytokinesis. J. Biol. Chem. 
279:4829–4839. 
De Souza, C.P., K.A. Ellem, and B.G. Gabrielli. 2000. Centrosomal and cyto-
plasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events. Exp. 
Cell Res. 257:11–21. 
Diviani, D., L.K. Langeberg, S.J. Doxsey, and J.D. Scott. 2000. Pericentrin an-
chors protein kinase A at the centrosome through a newly identified RII-
binding domain. Curr. Biol. 10:417–420. 
Dutertre, S., M. Cazales, M. Quaranta, C. Froment, V. Trabut, C. Dozier, G. Mirey, 
J.P. Bouche, N. Theis-Febvre, E. Schmitt, et al. 2004. Phosphorylation of 
CDC25B by aurora-A at the centrosome contributes to the G2-M transition. 
J. Cell Sci. 117:2523–2531. 
Gillingham, A.K., and S. Munro. 2000. The PACT domain, a conserved centro-
somal targeting motif in the coiled-coil proteins AKAP450 and pericen-
trin. EMBO Rep. 1:524–529.